Is AstraZeneca PLC (AZN) A Good Stock To Buy Now?
Key takeaways
- Is Astra Zeneca PLC (AZN) A Good Stock To Buy Now?
- The modern company emerged after the 1993 demerger of Zeneca from ICI and its subsequent merger with Astra AB in 1999, combining complementary strengths across therapeutic areas.
- Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Is Astra Zeneca PLC (AZN) A Good Stock To Buy Now? Ricardo Pillai Sun, May 3, 2026 at 11:22 PM GMT+7 3 min read AZN Is AZN a good stock to buy? We came across a bullish thesis on Astra Zeneca PLC on South Sea Investing’s Substack. In this article, we will summarize the bulls’ thesis on AZN. Astra Zeneca PLC s share was trading at $195.78 as of April 21st. AZN’s trailing and forward P/E were 30.69 and 19.23 respectively according to Yahoo Finance.
Astra Zeneca PLC has evolved from its origins in the 19th-century chemicals industry into one of the world’s leading pharmaceutical companies, with roots tracing back to Nobel Industries and the formation of Imperial Chemical Industries (ICI). The modern company emerged after the 1993 demerger of Zeneca from ICI and its subsequent merger with Astra AB in 1999, combining complementary strengths across therapeutic areas.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich